PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -91.65 Billion | 40.99 Billion | -18.17 Billion | 71.69 Billion | -25.26 Billion | 4.72 Billion |
| Net Income | 33.08 Billion | 24.46 Billion | 9.57 Billion | 2.8 Billion | 7.88 Billion | 19.44 Billion |
| Depreciation & Amortization | 18.97 Billion | 16.53 Billion | 15.78 Billion | 15.48 Billion | 5.86 Billion | 4.72 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -143.71 Billion | -40.99 Billion | -43.53 Billion | 53.4 Billion | -39 Billion | -24.16 Billion |
| Investing Cash Flow | -5.52 Billion | -14.6 Billion | -4.2 Billion | -3.81 Billion | -10.62 Billion | -5.94 Billion |
| Investments in PPE | -21.51 Billion | -14.67 Billion | -4.47 Billion | -3.81 Billion | -10.81 Billion | -6.35 Billion |
| Acquisitions | 15.99 Billion | 69.91 Million | 267.27 Million | 850 Thousand | 192.47 Million | 407 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 14.41 Billion | -9.24 Billion | 267.27 Million | 850 Thousand | 192.47 Million | 407 Million |
| Financing Cash Flow | 130.4 Billion | 102.86 Billion | 21.68 Billion | -49.31 Billion | 27.69 Billion | 114.15 Billion |
| Debt repayment | -142.97 Billion | -2136.44 Billion | -22.72 Billion | -47.68 Billion | -71.68 Billion | -8.28 Million |
| Dividends payments | -2.54 Billion | -1.27 Billion | -637 Million | -1.27 Billion | -3.82 Billion | -2.54 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.19 Billion | 2240.58 Billion | 45.04 Billion | -359.99 Million | 103.19 Billion | 116.7 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 25.66 Billion | 47.36 Billion | 48.05 Billion | 29.49 Billion | 37.68 Billion | 56.46 Billion |
| Cash at end of period | 58.89 Billion | 25.66 Billion | 47.36 Billion | 48.05 Billion | 29.49 Billion | 37.68 Billion |
| Capital Expenditure | -21.51 Billion | -14.67 Billion | -4.47 Billion | -3.81 Billion | -10.81 Billion | -6.35 Billion |
| Effect of forex changes on cash | - | -150.94 Billion | 339.64 Thousand | 392.43 Thousand | -1.15 Million | 1.92 Million |
| Net cash flow / Change in cash | 33.23 Billion | -21.69 Billion | -691.99 Million | 18.56 Billion | -8.19 Billion | -18.77 Billion |
| Free Cash Flow | -113.17 Billion | 26.31 Billion | -22.64 Billion | 67.87 Billion | -36.07 Billion | -1.63 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.13 Billion | 8.24 Billion | 7.09 Billion | 33.08 Billion | 6.35 Billion | 3.58 Billion |
| Depreciation & Amortization | 5.99 Billion | 5.61 Billion | 5.63 Billion | 18.97 Billion | 5.02 Billion | 4.89 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -12.54 Billion | -48.77 Billion | -102.56 Billion | -143.71 Billion | 29.4 Billion | -79.67 Billion |
| Investing Cash Flow | -3.88 Billion | -2.89 Billion | -2.58 Billion | -5.52 Billion | -11.13 Billion | -4.58 Billion |
| Investments in PPE | -1.11 Billion | -2.89 Billion | -929.44 Million | -21.51 Billion | -11.75 Billion | -1.93 Billion |
| Acquisitions | - | - | - | 15.99 Billion | 618.39 Million | 450.45 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -271.84 Million | -1.65 Billion | 14.41 Billion | 4.81 Billion | -2.65 Billion |
| Financing Cash Flow | -771.13 Million | 28.06 Billion | 80.11 Billion | 130.4 Billion | 12.38 Billion | 55.05 Billion |
| Debt repayment | -2.41 Billion | -28.06 Billion | -80.11 Billion | -142.97 Billion | -5.5 Billion | -616.77 Billion |
| Dividends payments | -3.18 Billion | - | - | -2.54 Billion | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.00 | -1.00 | - | -9.19 Billion | 7.7 Billion | 671.82 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 14.35 Billion | 35.32 Billion | 58.89 Billion | 25.66 Billion | 16.85 Billion | 37.58 Billion |
| Cash at end of period | 8.28 Billion | 14.35 Billion | 35.32 Billion | 58.89 Billion | 58.89 Billion | 16.85 Billion |
| Capital Expenditure | -1.11 Billion | -2.89 Billion | -929.44 Million | -21.51 Billion | -11.75 Billion | -1.93 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.06 Billion | -20.96 Billion | -23.57 Billion | 33.23 Billion | 42.04 Billion | -20.72 Billion |
| Free Cash Flow | -2.52 Billion | -49.03 Billion | -102.03 Billion | -113.17 Billion | 29.04 Billion | -73.12 Billion |
INDTERRAIN
AMSSY
TEXRAIL
600177
HGKGF
6979